Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/378
Type
ArticleCopyright
Restricted access
Collections
- IFF - Artigos de Periódicos [1300]
Metadata
Show full item record
FIVE HAPLOTYPES ACCOUNT FOR FIFTY-FIVE PERCENT OF ATM MUTATIONS IN BRAZILIAN PATIENTS WITH ATAXIA TELANGIECTASIA: SEVEN NEW MUTATIONS
Polimorfismo de Um Único Nucleotídeo - genética
Proteínas Serina-Treonina Quinases - genética
Mutação - genética
Haplotipos
Author
Affilliation
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
Universidade Federal de São Paulo. Imunologia Clínica e Reumatologia. Departamento de Pediatria. Divisão de Alergia. São Paulo, SP, Brasil.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
Stanford University. Stanford Genome Technology Center. Palo Alto, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
Laboratório Genetika, PR, Brazil
USP. Instituto da Criança do Hospital das Clínicas. Departamento de Genética Clínica. São Paulo, SP, Brasil
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
Universidade Federal de São Paulo. Imunologia Clínica e Reumatologia. Departamento de Pediatria. Divisão de Alergia. São Paulo, SP, Brasil.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
Stanford University. Stanford Genome Technology Center. Palo Alto, California, EUA.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
Laboratório Genetika, PR, Brazil
USP. Instituto da Criança do Hospital das Clínicas. Departamento de Genética Clínica. São Paulo, SP, Brasil
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
The David Geffen School of Medicine. Department of Pathology and Laboratory Medicine. Los Angeles, California, EUA.
Abstract
We have studied the molecular genetics of 27 Brazilian families with ataxia telangiectasia (AT). Five founder effect haplotypes accounted for 55.5 per cent of the families. AT is an autosomal recessive disorder of childhoodonset characterized by progressive cerebellar ataxia, ocular apraxia, telangiectasia, immunodeficiency, radiation sensitivity, chromosomal instability, and predispositionto cancer. The ATM gene spans more than 150 kb on chromosome region 11q23.1 and encodes a product of 3,056 amino acids. The ATM protein is a member of the phosphatidylinositol 3-kinase (PI-3K) family of proteins and is involved in cell cycle control and DNA repair pathways. DNA was isolatedfrom lymphoblastoid cell lines and haplotyped using four STR markers (D11S1818, NS22, D11S2179, D11S1819) within and flankingthe ATM gene; all allele sizes were standardized in advance. In addition to the STR haplotypes,SNP haplotypes were determined using 10 critical polymorphisms. The entire gene was screened sequentially by protein truncation testing (PTT), single strand conformation polymorphism (SSCP), and then denaturing high performance liquid chromatography (dHPLC) to identify the disease-causing mutations. Of the expected 54 mutations, 50 were identified. All mutations but one, led to a truncated or null form of the ATM protein (nonsense, splice site, or frameshift). Five families (18.5 per cent) carried a deletion of 3450nt (from IVS28 to Ex31), making this one of the two most common Brazilian mutations. Mutations were located throughout the entire gene, with no clustering or hotspots. Standardized STR haplotype analysis greatly enhanced the efficiency of mutation screening.
DeCS
Ataxia Telangiectasia - genéticaPolimorfismo de Um Único Nucleotídeo - genética
Proteínas Serina-Treonina Quinases - genética
Mutação - genética
Haplotipos
Share